general
- Generic Name : Vaccinia Immune Globulin Intravenous
- Pronunciation : Vac-SIN-ee-a im-yoon GLOB-u-lin IN-tra-ve-nas
- ICD Code : Y59.3
- Therapeutic Classification : Immunizing Agents
- Trade Names/Brand Names(International) : VIGIV
prescription
Prescribed for accidental implantation, eczema vaccinatum, generalized vaccinia, and progressive vaccinia, this medication is the sole recognized antidote to the complications of vaccination.
risk factors
It is not advisable to use in the presence of isolated vaccinia keratitis.
side effects
- Most Common : Headache, nausea, dizziness, feeling hot, feeling cold and rigors.
- Respiratory : Bluish, low blood oxygen pressure, pulmonary edema, dyspnea, bronchospasm.
- Heart : Thromboembolism, low blood pressure.
- Central Nervous System : Seizures, tremor.
- Blood : Hemolysis, positive direct antiglobulin (Coombs) test.
- Body : Fever, rigors.
- Musculoskeletal : Back pain.
- Gastrointestinal : Hepatic dysfunction, abdominal pain.
dosage
Intravenous (IV) administration: The recommended dose is 6000 units per kilogram (U/kg).
how to take
It is available as a solution for injection, intended to be administered by a healthcare provider into the vein.
warning
Caution is advised in patients with a history of any allergy and during pregnancy and breastfeeding.
storage
2 to 8°C